MedPath

河北御芝林药业有限公司

Ownership
-
Established
2004-03-17
Employees
-
Market Cap
-
Website
https://www.yuzhl.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

55

NMPA:55

Drug Approvals

极元牌灵芝大豆肽软胶囊

Approval Number
国食健注G20220011
Approval Date
Apr 6, 2022
NMPA

极元牌西洋参蛹虫草胶囊

Approval Number
国食健注G20120122
Approval Date
Jan 25, 2022
NMPA

臻通集牌三七丹参黄芪胶囊

Approval Number
国食健注G20160114
Approval Date
Jan 25, 2022
NMPA

优韧集牌三七氨糖骨碎补胶囊

Approval Number
国食健注G20160215
Approval Date
Jan 25, 2022
NMPA

金多盖牌酪蛋白磷酸肽钙胶囊

Approval Number
国食健注G20141027
Approval Date
Jan 25, 2022
NMPA

臻草牌红景天粉

Approval Number
国食健注G20130020
Approval Date
Apr 12, 2021
NMPA

固龙集牌姬松茸葛根精氨酸片

Approval Number
国食健注G20120385
Approval Date
Apr 12, 2021
NMPA

双黄消炎片

Approval Number
国药准字Z20063846
Approval Date
Dec 21, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H20067688
Approval Date
Dec 21, 2020
NMPA

感冒清热颗粒

Approval Number
国药准字Z20064403
Approval Date
Dec 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.